Printed intelligence technology for mass production of analytical devices

VTT Technical Research Centre of Finland and the University of California in Berkeley have begun a three-year project to address technology barriers in the field of low cost diagnostics.

The target of the cooperation is to transfer micro-scale devices made on glass or silicon to analytical devices which are applicable for mass production by roll-to-roll printing. Roll-to-roll printing technology will allow for a drastic reduction in price and increase in speed, which are necessities for large-scale utilisation of biochips in applications, e.g. in diagnostics, environment and food safety testing.

The challenges of this technology lie, for example, in creating multilayered structures with features in the range of tens of micrometers. The technology is part of VTT’s strategic research activities in the field of intelligent printing.

Long-term and visiting scientists from VTT will be working at the Berkeley laboratory, and a VTT research team in Finland will be producing and assembling components. The components will be tested in Berkeley and finally produced at VTT.

VTT’s aim is to facilitate collaboration between scientists and companies at Berkeley and Finland, and to produce new technologies and production processes for Finnish industries.

Further information:

Harri Siitari, Technology Manager, tel. +358 20 722 2832, [email protected]
Prof. Hans Söderlund, Vice President, Strategic Research, tel. +358 20 722 5104, [email protected]

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aptamer extends agreement with genetic medicines customer